Interfacial interactions of apolipoprotein AI and high density lipoprotein: Overlooked phenomena in blood-material contact

被引:11
|
作者
Cornelius, Rena M. [1 ,2 ]
Macri, Joseph [2 ]
Brash, John L. [1 ,3 ]
机构
[1] McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada
[2] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada
[3] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
apolipoprotein AI; lipoproteins; protein adsorption; plasma; SDS-PAGE; immunoblot; AMPHIPATHIC PEPTIDE ANALOGS; MYOCARDIAL-INFARCTION; PROTEIN ADSORPTION; ALGINATE MICROCAPSULES; BIOMATERIAL SURFACES; PROTEOMIC ANALYSIS; APOA-I; PLASMA; POLYURETHANE; FIBRINOGEN;
D O I
10.1002/jbm.a.33169
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Apolipoprotein AI (apo AI) is the major protein component of high density lipoprotein (HDL), and represents similar to 1% of the total protein content of plasma. In previous work, apo AI was identified as a major component of the protein layers adsorbed from plasma to biomaterials having a wide range of surface properties. Notwithstanding such indications of the major contribution of lipoprotein interactions, these phenomena have been largely overlooked in the blood-contacting biomaterials area. In this communication, detailed quantitative data on the adsorption of apo AI to typical "biomedical" segmented polyurethane (PU) are reported. Using radiolabeled apo AI, adsorption levels from buffer and plasma were found to be similar to 0.5 and similar to 0.2 mu g/cm(2), respectively. Albumin adsorption from plasma was comparable at about similar to 0.17 mu g/cm(2). Since, it is unknown how much of the adsorbed apo AI is associated with HDL versus how much is in the free state, the corresponding molar quantities cannot be determined with certainty. However, if it is assumed that all of the adsorbed apo AI is free, the molar quantities adsorbed from plasma were in the ratio apo AI: albumin 2.77, compared with 0.00063 in plasma. Immunoblot data showed similar trends with respect both to the variation in adsorbed quantity with plasma concentration and to the relative adsorbed quantities of apo AI and albumin. These data show unequivocally the very strong surface activity of apo AI and suggest that a key future focus for blood compatibility research should be lipoprotein interactions. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 99A: 109-115, 2011.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 14 条
  • [1] ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate
    Xu, Bingqing
    Gillard, Baiba K.
    Gotto, Antonio M., Jr.
    Rosales, Corina
    Pownall, Henry J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (12) : 2260 - +
  • [2] High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study
    R. Frénais
    K. Ouguerram
    C. Maugeais
    P. Mahot
    P. Maugère
    M. Krempf
    T. Magot
    Diabetologia, 1997, 40 : 578 - 583
  • [3] Chronic Hyperinsulinemia Does Not Increase the Production Rate of High-Density Lipoprotein Apolipoprotein AI Evidence From a Kinetic Study in Patients With Insulinoma
    Duvillard, Laurence
    Florentin, Emmanuel
    Pont, Frederic
    Petit, Jean-Michel
    Baillot-Rudoni, Sabine
    Penfornis, Alfred
    Verges, Bruno
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (10) : 2460 - 2465
  • [4] No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes
    Duvillard, Laurence
    de Barros, Jean-Paul Pais
    Rouland, Alexia
    Simoneau, Isabelle
    Denimal, Damien
    Bouillet, Benjamin
    Petit, Jean -Michel
    Verges, Bruno
    DIABETES & METABOLISM, 2024, 50 (03)
  • [5] Recombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecin
    Zhang, Xinbo
    Chen, Baosheng
    CANCER LETTERS, 2010, 298 (01) : 26 - 33
  • [6] ASSOCIATIONS OF GENOTYPES AT THE APOLIPOPROTEIN AI-CIII-AIV, APOLIPOPROTEIN-B AND LIPOPROTEIN-LIPASE GENE LOCI WITH CORONARY ATHEROSCLEROSIS AND HIGH-DENSITY-LIPOPROTEIN SUBCLASSES
    PEACOCK, RE
    HAMSTEN, A
    JOHANSSON, J
    NILSSONEHLE, P
    HUMPHRIES, SE
    CLINICAL GENETICS, 1994, 46 (04) : 273 - 282
  • [7] Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease
    Merched, A
    Xia, Y
    Visvikis, S
    Serot, JM
    Siest, G
    NEUROBIOLOGY OF AGING, 2000, 21 (01) : 27 - 30
  • [8] Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus
    Frénais, R
    Ouguerram, K
    Maugeais, C
    Mahot, P
    Charbonnel, B
    Magot, T
    Krempf, M
    ATHEROSCLEROSIS, 2001, 157 (01) : 131 - 135
  • [9] A Novel Compound Inhibits Reconstituted High-Density Lipoprotein Assembly and Blocks Nascent High-Density Lipoprotein Biogenesis Downstream of Apolipoprotein AI Binding to ATP-Binding Cassette Transporter A1-Expressing Cells
    Lyssenko, Nicholas N.
    Brubaker, Gregory
    Smith, Bradley D.
    Smith, Jonathan D.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (11) : 2700 - U879
  • [10] ABCA1 Mediates Unfolding of Apolipoprotein AI N Terminus on the Cell Surface Before Lipidation and Release of Nascent High-Density Lipoprotein
    Wang, Shuhui
    Gulshan, Kailash
    Brubaker, Gregory
    Hazen, Stanley L.
    Smith, Jonathan D.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (06) : 1197 - +